PFO
TWST icon

Pathstone Family Office’s Twist Bioscience TWST Stock Holding History

Pathstone Family Office’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,985
Closed -$212K – 960
2021
Q3 		$212K Buy
1,985
+454
+30% +$52K 0.01% 801
2021
Q2 		$204K Buy
+1,531
New +$178K 0.01% 770

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pathstone Family Office's TWST Position: Q4 2021 in Review

Pathstone Family Office sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 1,985 shares — an estimated $212K sold.

Pathstone Family Office first reported a position in TWST in Q2 2021 and held it in 2 quarters. The position peaked at $212K in Q3 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • Pathstone Family Office reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
  • Pathstone Family Office sold 1,985 Twist Bioscience shares in Q4 2021, an estimated $212K.
  • Pathstone Family Office first reported a position in Twist Bioscience in Q2 2021 and held it in 2 quarters.
  • Pathstone Family Office's Twist Bioscience position peaked at $212K in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Pathstone Family Office's 13F filing for Q4 2021, filed 14 Feb 2022.